Startseite>>Isotope-Labeled Compounds>> Deuterium>>MBDB-d3 (hydrochloride)

MBDB-d3 (hydrochloride) (Synonyms: N-Methyl-1,3-Benzodioxolylbutanamine-d3)

Katalog-Nr.GC47604

A neuropeptide with diverse biological activities

Products are for research use only. Not for human use. We do not sell to patients.

MBDB-d3 (hydrochloride) Chemische Struktur

Cas No.: 1794810-75-5

Größe Preis Lagerbestand Menge
500 μg
111,00 $
Auf Lager
1 mg
213,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

MBDB-d3 (hydrochloride) contains three deuterium atoms. It is intended for use as an internal standard for the quantification of MBDB by GC- or LC-mass spectrometry. MBDB is an analog of methylenedioxymethamphetamine (MDMA), differing only by the substitution of an ethyl for methyl group at the α-carbon. Like MDMA, MBDB is an entactogen that potently inhibits monoamine uptake.1,2 This product is intended for forensic and research purposes.

1.Nichols, D.E., Brewster, W.K., Johnson, M.P., et al.Nonneurotoxic tetralin and indan analogues of 3,4-(methylenedioxy)amphetamine (MDA)Journal of Medicinal Chemistry33(2)703-710(1990) 2.Nagai, F., Nonaka, R., and Satoh Hisashi Kamimura, K.The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brainEur. J. Pharmacol.559(2-3)132-137(2007)

Bewertungen

Review for MBDB-d3 (hydrochloride)

Average Rating: 5 ★★★★★ (Based on Reviews and 9 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for MBDB-d3 (hydrochloride)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.